[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn, Virginia.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 61, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 661800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 54, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 537800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gordon Bruce Dunn J.D.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 523385, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.21, "open": 1.34, "dayLow": 1.13, "dayHigh": 1.3689, "regularMarketPreviousClose": 1.21, "regularMarketOpen": 1.34, "regularMarketDayLow": 1.13, "regularMarketDayHigh": 1.3689, "beta": 2.123, "trailingPE": 0.85507244, "forwardPE": -0.17176127, "volume": 2481241, "regularMarketVolume": 2481241, "averageVolume": 544156, "averageVolume10days": 3103290, "averageDailyVolume10Day": 3103290, "bid": 1.18, "ask": 1.19, "bidSize": 1100, "askSize": 800, "marketCap": 1164919, "fiftyTwoWeekLow": 1.13, "fiftyTwoWeekHigh": 12.0, "fiftyDayAverage": 3.53694, "twoHundredDayAverage": 4.87923, "currency": "USD", "enterpriseValue": -9142824, "floatShares": 967525, "sharesOutstanding": 987220, "sharesShort": 2659, "sharesShortPriorMonth": 793, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0027, "heldPercentInsiders": 0.01964, "heldPercentInstitutions": 0.08564, "shortRatio": 0.17, "shortPercentOfFloat": 0.0027, "impliedSharesOutstanding": 987220, "bookValue": 7.51, "priceToBook": 0.15712382, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -8637655, "trailingEps": 1.38, "forwardEps": -6.87, "lastSplitFactor": "1:12", "lastSplitDate": 1689638400, "enterpriseToEbitda": 1.0, "52WeekChange": -0.8085586, "SandP52WeekChange": 0.33757293, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "QNRX", "underlyingSymbol": "QNRX", "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "firstTradeDateEpochUtc": 1470058200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "32cb2815-c927-3d74-8136-d444e5765139", "messageBoardId": "finmb_593010770", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.18, "targetHighPrice": 240.0, "targetLowPrice": 3.4, "targetMeanPrice": 86.13, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 13981477, "totalCashPerShare": 14.162, "ebitda": -9142727, "totalDebt": 3673733, "quickRatio": 3.052, "currentRatio": 3.087, "debtToEquity": 49.553, "returnOnAssets": -0.36686, "returnOnEquity": -1.04185, "freeCashflow": -3293436, "operatingCashflow": -6583126, "financialCurrency": "USD", "trailingPegRatio": null}]